PURPOSE: Hypospadias is one of the most frequent genital malformations in the male newborn, and results from abnormal penile and urethral development. The etiology of hypospadias remains largely unknown despite intensive investigations. Fetal androgens have a crucial role in genital differentiation. Recent studies have suggested that molecular mechanisms that underlie the effects of androgens on the fetus may involve disruption of epigenetic programming of gene expression during development. We assessed whether epigenetic modification of DNA methylation is associated with hypospadias in a case-control study of 12 hypospadias and 8 control subjects. MATERIALS AND METHODS: Genome-wide DNA methylation profiling was performed on the study subjects using the Illumina Infinium® HumanMethylation450 BeadChip, which enables the direct investigation of methylation status of more than 485,000 individual CpG sites throughout the genome. The methylation level at each CpG site was compared between cases and controls using the t test and logistic regression. RESULTS: We identified 14 CpG sites that were associated with hypospadias with p <0.00001. These CpG sites were in or near the SCARB1, MYBPH, SORBS1, LAMA4, HOXD11, MYO1D, EGFL7, C10orf41, LMAN1L and SULF1 genes. Two CpG sites in SCARB1 and MYBPH genes remained statistically significant after correction for multiple testing (p = 2.61 × 10(-09), p(corrected) = 0.008; p = 3.06 × 10(-08), p(corrected) = 0.02, respectively). CONCLUSIONS: To our knowledge this is the first study to investigate hypospadias using a unique and novel epigenetic approach. Our findings suggest DNA methylation patterns are useful in identifying new genes such as SCARB1 and MYBPH that may be involved in the etiology of hypospadias.
PURPOSE:Hypospadias is one of the most frequent genital malformations in the male newborn, and results from abnormal penile and urethral development. The etiology of hypospadias remains largely unknown despite intensive investigations. Fetal androgens have a crucial role in genital differentiation. Recent studies have suggested that molecular mechanisms that underlie the effects of androgens on the fetus may involve disruption of epigenetic programming of gene expression during development. We assessed whether epigenetic modification of DNA methylation is associated with hypospadias in a case-control study of 12 hypospadias and 8 control subjects. MATERIALS AND METHODS: Genome-wide DNA methylation profiling was performed on the study subjects using the Illumina Infinium® HumanMethylation450 BeadChip, which enables the direct investigation of methylation status of more than 485,000 individual CpG sites throughout the genome. The methylation level at each CpG site was compared between cases and controls using the t test and logistic regression. RESULTS: We identified 14 CpG sites that were associated with hypospadias with p <0.00001. These CpG sites were in or near the SCARB1, MYBPH, SORBS1, LAMA4, HOXD11, MYO1D, EGFL7, C10orf41, LMAN1L and SULF1 genes. Two CpG sites in SCARB1 and MYBPH genes remained statistically significant after correction for multiple testing (p = 2.61 × 10(-09), p(corrected) = 0.008; p = 3.06 × 10(-08), p(corrected) = 0.02, respectively). CONCLUSIONS: To our knowledge this is the first study to investigate hypospadias using a unique and novel epigenetic approach. Our findings suggest DNA methylation patterns are useful in identifying new genes such as SCARB1 and MYBPH that may be involved in the etiology of hypospadias.
Authors: A Vottero; R Minari; I Viani; F Tassi; F Bonatti; T M Neri; L Bertolini; S Bernasconi; L Ghizzoni Journal: J Clin Endocrinol Metab Date: 2011-09-21 Impact factor: 5.958
Authors: L F M van der Zanden; I A L M van Rooij; W F J Feitz; B Franke; N V A M Knoers; N Roeleveld Journal: Hum Reprod Update Date: 2012-02-26 Impact factor: 15.610
Authors: S Bens; O Ammerpohl; J I Martin-Subero; M Appari; J Richter; O Hiort; R Werner; F G Riepe; R Siebert; P-M Holterhus Journal: Sex Dev Date: 2011-02-11 Impact factor: 1.824
Authors: Robert C Gentleman; Vincent J Carey; Douglas M Bates; Ben Bolstad; Marcel Dettling; Sandrine Dudoit; Byron Ellis; Laurent Gautier; Yongchao Ge; Jeff Gentry; Kurt Hornik; Torsten Hothorn; Wolfgang Huber; Stefano Iacus; Rafael Irizarry; Friedrich Leisch; Cheng Li; Martin Maechler; Anthony J Rossini; Gunther Sawitzki; Colin Smith; Gordon Smyth; Luke Tierney; Jean Y H Yang; Jianhua Zhang Journal: Genome Biol Date: 2004-09-15 Impact factor: 13.583
Authors: Cindy Hudson; Corbin Schwanke; John P Johnson; Abdallah F Elias; Sandy Phillips; Tammy Schwalbe; Mary Tunby; Dongbin Xu Journal: Am J Med Genet A Date: 2014-04-08 Impact factor: 2.802
Authors: Edwina H Yeung; Pauline Mendola; Rajeshwari Sundaram; Xuehuo Zeng; Weihua Guan; Michael Y Tsai; Sonia L Robinson; Judy E Stern; Akhgar Ghassabian; David Lawrence; Thomas G O'Connor; James Segars; Robert E Gore-Langton; Erin M Bell Journal: Fertil Steril Date: 2021-04-03 Impact factor: 7.490
Authors: Melissa A Richard; Pagna Sok; Stephen Canon; Wendy N Nembhard; Austin L Brown; Erin C Peckham-Gregory; Minh Ton; Erik A Ehli; Noah A Kallsen; Shanna A Peyton; Gareth E Davies; Ashay Patel; Ismael Zamilpa; Charlotte A Hobbs; Michael E Scheurer; Philip J Lupo Journal: Sci Rep Date: 2020-07-29 Impact factor: 4.379
Authors: David A Armstrong; Benjamin B Green; Bailey A Blair; Dylan J Guerin; Julia F Litzky; Niraj R Chavan; Kevin J Pearson; Carmen J Marsit Journal: Environ Epigenet Date: 2016-10-20